Advertisement Cognizant extends agreement with Merck - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cognizant extends agreement with Merck

Information technology company Cognizant has reported a multi-year, multi-million dollar engagement with pharmaceutical company Merck & Co.

Cognizant will extend its existing relationship with Merck, dating back to 2005, to become a key technology partner and provide a full suite of services encompassing applications outsourcing, IT infrastructure management and business process outsourcing services.

Francisco D’Souza, president and CEO of Cognizant, said: “With Cognizant’s expertise in the healthcare and life sciences industry, we are proud to be chosen by Merck as a trusted IT partner to deliver services globally for them. Our ability to integrate applications, infrastructure and business processes, coupled with our global delivery model, enables us to provide Merck with a strong platform for its global transformational initiatives.”

Rich Branton, vice president, global technology solutions, Merck & Co, said: “Over the past two years, Merck has leveraged Cognizant’s extensive pharmaceutical expertise to streamline operational efficiencies and to consolidate our IT portfolio. We selected Cognizant as our ongoing strategic partner for the full suite of IT services as a result of our previous engagements and Cognizant’s deep domain experience and leadership position in our space.”